Skip to content
Open access

Lateral sclerosis in amyotrophic lateral sclerosis is an upper motor neuron distal axonopathy (“dying back”): a clinical-neuropathological study

Oct 2026 · Acta Neuropathologica · Vol 152 · 1 citation · 79 references
Medicine

TL;DR

“lateral sclerosis” of ALS correlates to clinically imputed UMN degeneration, which consists of a combination of myelin loss, distal greater than proximal axonal degeneration, inflammatory microglial activation within the CSTs, and abnormally increased axonal TDP-43.

Abstract

The hallmark neuropathological feature of upper motor neuron (UMN) degeneration in amyotrophic lateral sclerosis (ALS) is the “sclerosis” of the lateral corticospinal tract (CST)—the major axonal pathway connecting UMNs to lower motor neurons (LMNs). However, few studies since Charcot’s original descriptions in the nineteenth century have directly correlated clinical UMN phenotypes with corresponding neuropathological findings. We examined the pathology of the lateral CST at the cervical, thoracic, and lumbar levels of the spinal cord from ALS patients with predominantly UMN (UMN-p) phenotypes and compared it with that in patients with predominantly LMN (LMN-p) phenotypes. We assessed myelin loss, axonal degeneration, neuroinflammation, and TDP-43 pathology. Spinal cords from UMN-p ALS cases exhibited pronounced myelin loss in the lateral CST compared to LMN-p cases and controls, consistent with clinical phenotyping. Quantitative analysis revealed significant axonal loss across all axon diameter ranges in UMN-p ALS, which was more severe than in LMN-p ALS. Importantly, axonal loss was more pronounced in the lumbar than in the cervical spinal cord. We identified a distinct population of foamy, inflammatory microglia localized to regions of severe myelin and axonal loss in UMN-p ALS. TDP-43 was measurably increased in the UMN axons of the lateral and ventral CSTs. In summary, “lateral sclerosis” of ALS correlates to clinically imputed UMN degeneration. It consists of a combination of myelin loss, distal greater than proximal axonal degeneration, inflammatory microglial activation within the CSTs, and abnormally increased axonal TDP-43. The length-dependent gradient of motor axonal loss supports a "dying-back" process. A detailed comparison of “dying-forward” and “dying-forward” is provided in the Discussion. The association of loss of axons and myelin with abnormal microglial activity shows glio-axonal interactions in UMN axon degeneration, the latter CST (lateral sclerosis) across all three spinal cord levels in the ALS UMN-p samples but does not establish a causal relationship.

Read PDF

Similar papers

Open access Oct 2026

Motor neuron disease masquerading as sensorimotor polyneuropathy

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder, initially defined as a purely motor neuron disease (MND), marked by the progressive degeneration of motor neurons in the motor cortex, brainstem, and spinal cord. Now it is recognized as a multisystem disease, with cognitive, gastrointestinal, a...

P. Kashyap, Mayur Bhat, Dharmendra Singh et al. · 0 citations
Review Open access Oct 2026

Neuromuscular junction pathology in amyotrophic lateral sclerosis and emerging molecular therapeutic strategies.

Traditionally conceptualized as a soma-centric pathology, amyotrophic lateral sclerosis (ALS) is a fatal, heterogeneous neurodegenerative disease. The suboptimal outcomes of central nervous system (CNS)-directed therapeutic strategies have necessitated a shift in focus toward the dying-back hypothesis. This hypothesis...

Kazuki Okoshi, Yoshitsugu Aoki · 0 citations
Oct 2026

White matter hyperintensity burden in amyotrophic lateral sclerosis: motor and survival correlates.

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive motor neuron degeneration. Microvascular dysfunction has been implicated by recent research in ALS pathogenesis and motor neuron vulnerability. The aim of this study is to investigate whether MRI markers of white matt...

A. de Lorenzo, A. Maranzano, A. Cocuzza et al. · 0 citations
Review Oct 2026

Revisiting the muscle spindle in ALS: Implications for spinal motor network dysfunction

A temporal model of human ALS is presented, linking fusimotor denervation to progressive disruption of spinal inhibitory and excitatory circuits, and proposes that this gain-control failure, compounded by the loss of associated alpha–gamma coactivation and beta skeletofusimotor denervation constitutes an upstream drive...

José Castro, M. de Carvalho, M. Swash · 0 citations
Open access Oct 2026

Multimodal diagnostic tools in amyotrophic lateral sclerosis: insights from an illustrative case series

Background: ALS is a neurodegenerative disorder with a broad phenotypic spectrum. Diagnosis is challenging in non-classical presentations or early in the disease course. Beyond electromyography, complementary tests may provide evidence of lower motor neuron (LMN) and upper motor neuron (UMN) dysfunction and help exclud...

A. Mendes, Filipe Tupinambá Di Pace, G. Dousseau et al. · 0 citations
Review Open access Oct 2026

Treatable cervical mimics of motor neuron disease: a case series

Background: Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder affecting upper and lower motor neurons. Many conditions may mimic ALS, especially cervical spine pathology. Recognizing these mimics is crucial, since some of them are treatable. Objective: To describe four clinical cases of different cerv...

F. Gomez, Filipe Tupinambá Di Pace, Rodrigo de Holanda Mendonça et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.